Recovery

ARA-290

Repair · 98.9% · HPLC · Batch G260760

Tracked EU shipping €9.95 — free on net goods ≥ €150. Ships after batch confirmation; verify the ID on the label when it arrives.

An EPO-derived peptide studied for nerve repair and neuropathic pain.

Stacks: Researched on its own; occasionally with BPC-157 for nerve-tissue work.

PROVENANCE · SUPPLIER → BENCH

German supplier

Lot received · Frankfurt

2026-03-17

Batch intake

Logged & quarantined

2026-03-20

HPLC test

Purity confirmed

2026-04-17

Serialised

Unique QR per vial

2026-04-19

Released

QA sign-off complete

2026-04-22

Dispatch ready

Cold-chain where required

2026-04-23

Variant

€49.99

Formatlyophilised vial
Verify IDTV-2607-60K26-07V60

HPLC purity read-out

Hover or focus a peak to see what it is. Impurity peaks are enlarged for clarity.

036912retention time (min)signal (mAU)
98.9% purity (HPLC)largest single impurity 0.64% · spec ≤ 1.0%total impurities 1.1%

Storage & handling

  • Store lyophilised vials refrigerated at 2–8 °C, protected from light and moisture.
  • Do not freeze lyophilised material unless the batch record states otherwise.
  • Keep vials upright in the original carton until reconstitution.
Reconstituted
  • After reconstitution with bacteriostatic water, refrigerate at 2–8 °C.
  • Typical research use window: within 28 days when using BAC water (batch-dependent).
  • Discard if the solution becomes cloudy, discoloured, or particulate.
Handling
  • Use aseptic technique; wipe the stopper with an alcohol swab before each draw.
  • Do not shake vigorously — swirl gently to dissolve.
  • For laboratory research use only. Not for human or veterinary use.

Evidence dossier

ARA-290 — analytical notes

Cited literature and method notes for laboratory researchers. Not therapeutic claims — read the primary sources.

Analytical method

  • Identity confirmed by mass spectrometry against the target sequence.
  • Purity reported by HPLC with method retained in the batch record.
  • Endotoxin and water content disclosed on the Certificate of Analysis.

Storage & stability

  • Store lyophilised vials refrigerated at 2–8 °C, protected from light and moisture.
  • Do not freeze lyophilised material unless the batch record states otherwise.
  • Use aseptic technique; wipe the stopper with an alcohol swab before each draw.

Known impurities / release gates

Related-peptide and process impurities are screened on HPLC; out-of-spec batches are quarantined.

Reference literature

  • ARA-290 neuropathic repair peptide studiesNeuropathy trials · 2014
  • ARA-290 diabetic neuropathy exploratory trialsNeuropathy research · 2015

Related compounds · Repair

Frequently asked

Is ARA-290 available in Ireland and the EU?

Yes — ARA-290 ships tracked from EU-held stock to Ireland and across the EU, with no non-EU customs step. For laboratory research use only; not for human or veterinary use.

How do I verify a ARA-290 batch?

Every TARA vial carries a unique verification ID. Enter it at tararesearch.ie/verify to see the batch's Certificate of Analysis, HPLC purity result, and release status — no account needed. The current catalogue batch is G260760.

What purity is ARA-290?

Batch G260760 tested at 98.9% by HPLC. The full report, including the chromatogram, is public in the batch's Certificate of Analysis.

How is ARA-290 supplied and stored?

Supplied as lyophilised vial. Store lyophilised material cool, dry, and away from light; see the storage and handling guidance on this page for details.